CVS Health president and CEO Larry Merlo will share his insights on the accelerated pace of change in health care and his vision for transforming America's $3.6 trillion health care system at Town Hall Los Angeles.
Mylan is introducing the first generic of Baxter’s Brevibloc injection, which had a market value of approximately $126 million for the 12 months ending June 30, according to IQVIA.
The Rite Aid Foundation announced that 422 students were selected as recipients of the 2018 Folds of Honor educational scholarship through its KidCents program.
Bob Richardson, the director of sales and customer industry development at Clorox, was awarded the GMDC's annual Lifetime Achievement Award at the associations Health Beauty Wellness conference.
Sun Pharma's Xelpros, approved by the FDA, is the first and only form of latanoprost that is not formulated with benzalkonium chloride (BAK), a preservative commonly used in topical ocular preparations.